NEU neuren pharmaceuticals limited

Ann: Trading Halt, page-35

  1. 2,890 Posts.
    lightbulb Created with Sketch. 502
    Sillaze's post translated

    The numbers of this operation are surgical for the main purpose of armoring the title on the market by finalizing a partnership that begins to reinforce the suspicion that ends up in an acquisition; I say this because those who buy or who decide to invest heavily in the Neuren project (including NNZ-2591) claims assurances that there are no surprises for the majority in the decision table.
    The numbers I refer to are:
    Thursday will allocate another 100 million shares bringing total shares to 1.94 billion.
    The Walker had so far 19%, so he was about 1.84 billion, or about 350 million. In an extraordinary meeting to ask shareholders for Walker's up to 24% positive votes were 475 million excluding those of Walker who obviously did not have the right to vote, so adding that we would have reached 825 million that would represent the 45% of the shares. Now with a total that will rise to 1.94 billion and a Walker with 450 million, net of the faithful 475 million, + the new Walker's position is 925 million, which is 47%. The rest of just over 3% to reach armor is about 80 million in the hands of executives; Look at Hancox, Treagus and Glass shares held by Shake and Pilcher as soon as they announce Stage 3 as stock plan matured at the end of May.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.54
Change
0.280(2.28%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.52 $12.73 $12.26 $8.152M 652.1K

Buyers (Bids)

No. Vol. Price($)
1 665 $12.50
 

Sellers (Offers)

Price($) Vol. No.
$12.55 235 1
View Market Depth
Last trade - 16.10pm 24/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.